Shining a Light on the Cost of Wound Care: How Point-of-Care Bacterial Imaging is Reducing Cost & Improving Care
Chronic wounds affect approximately 6.5 million patients in the United States, at an annual cost of billions of dollars. Bacterial infection often complicates chronic wounds and is a major driver of wound care expenses. When bacterial burden is identified and quantified early, appropriate treatment can be instituted promptly, thus promoting a positive healing trajectory and reducing wound care costs.
This illustrated guide by MolecuLight discusses contributors to the high costs of wound care, including bacterial infection, and offers a solution. MolecuLight i:X is a handheld, point-of-care imaging device using fluorescence to detect bacterial wound infection accurately and rapidly and to guide wound assessment, targeted cleaning and debridement, and inform treatment decision-making and monitoring. In clinical studies of more than 500 patients, MolecuLight i:X was demonstrated to be beneficial.
Wound care professionals will appreciate the informative and well-referenced discussions of wound care costs and fluorescence in bacterial imaging, as well as case studies of MolecuLight i:X use in real-world clinical settings and tips for wound assessment in the current pandemic.
This white paper covers the following topics:
Sponsored by MolecuLight